What’s Up With Diagnostics and Tools Stocks? Big Winners Are In Personalized Medicine- FMI, ILMN

lantus solostar pen price by | Dec 20, 2017 | 2018 Rayno Tools and Diagnostics Portfolio, Biopharmaceuticals, Clinical Diagnostics and Tools

protonix uk Clinical Diagnostics and Tools: Big Winners Are In Genomics and Personalized Medicine Slower growth in routine clinical diagnostics, tools are favored. Hologic has a unique business model for women’s health and diagnostics. Gene sequencing is important for...

Foundation Medicine (FMI): New Pick Added To Raygent Core Portfolio

imdur generic cost by | Jul 5, 2016 | 2018 Rayno Biopharmaceuticals Portfolio, 2018 Rayno Tools and Diagnostics Portfolio, Biopharmaceuticals

livial available usa Foundation Medicine (FMI) New Pick at $20.40 We have added Foundation Medicine (FMI) to our core portfolio because of their leadership position in pharmacogenomics and molecular medicine for cancer care. The Foundation One genomic profile helps physicians make...

Biotech Rally Gains Momentum…Update-1

retin a cream singapore where to buy by | Nov 19, 2015 | 2009-2017 Life Science Portfolios, 2018 Rayno Biopharmaceuticals Portfolio, 2018 Rayno Tools and Diagnostics Portfolio

Update-1 Rayno Recap for week of 11/20/15 IBB up 3.04%, XBI  up 1.92%,  XLV up 2.82% Notable Small Cap Winners Curis (CRIS) up 4.13%, Fibrocell Sciences (FCSC) up 3.42%, Geron (GERN) up 4.82%, Ignyta (RXDX) up 37.39%, and Ocera Therapeutics (OCRX) up 5.31%. Notable...

Pin It on Pinterest